PDA002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PDA002, covering 2018-03-01 to 2018-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU [Phase 1]